Case Study: Kowa Pharmaceuticals America achieves 14% higher quota attainment and faster, actionable sales insights with Optymyze's Sales Operations as a Service

Optymyze Helps Kowa Reengineer and Boost Sales Operations with Sales Operations as a Service

Kowa Pharmaceuticals America, a Japan-based firm focused on cardiometabolic therapeutics, expanded into the U.S. market and faced growing complexity in its sales model. With an inflexible, transactional SPM provider, Kowa struggled with inconsistent goal communication, poorly aligned incentives, weak analytics and reporting, and limited visibility for reps—prompting the company to seek a long-term, pharma-experienced partner. In October 2014 they engaged Optymyze’s Sales Operations as a Service (SOaaS).

Optymyze standardized processes, deployed technology and ongoing expert support to redesign compensation plans, provide real-time insights, and deliver weekly reports and continuous guidance. The partnership produced measurable gains: quota attainment rose 14%, reporting moved from monthly to weekly, time-to-value for sales insights fell by 80%, and reps gained clearer, fairer incentives and actionable plans to improve performance.

Kowa